HYUNDAI BIOLAND Co.,Ltd. (KOSDAQ:052260)
South Korea · Delayed Price · Currency is KRW 4,430.00
-5.00 (-0.11%)
At close: Feb 13, 2026
HYUNDAI BIOLAND Market Cap
HYUNDAI BIOLAND has a market cap or net worth of 132.9 billion as of February 13, 2026. Its market cap has decreased by -5.04% in one year.
Market Cap
132.90B
Enterprise Value
121.62B
Revenue
129.68B
Ranking
n/a
PE Ratio
10.68
Stock Price
4,430.00
Market Cap Chart
Since March 1, 2002, HYUNDAI BIOLAND's market cap has increased from 25.40B to 132.90B, an increase of 423.17%. That is a compound annual growth rate of 7.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 132.90B | 3.14% |
| Dec 30, 2025 | 128.85B | -4.87% |
| Dec 30, 2024 | 135.45B | -9.52% |
| Dec 28, 2023 | 149.70B | -25.80% |
| Dec 29, 2022 | 201.75B | -21.80% |
| Dec 30, 2021 | 258.00B | -29.65% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GREEN CROSS WellBeing | 165.38B |
| High Tech Pharm | 160.99B |
| Kyung Dong Pharmaceutical | 153.57B |
| DongKoo Bio & Pharma | 146.84B |
| BL Pharmtech | 144.87B |
| PHARMARESEARCH BIO | 144.86B |
| OPTUS Pharmaceutical | 141.17B |
| KOREA PHARMA | 138.73B |